J. Goldman & CO LP Corcept Therapeutics Inc Transaction History

J. Goldman & CO LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$21.1 - $27.46 $427,275 - $556,065	20,250 New	20,250 $510,000
Q4 2020 Feb 16, 2021	SELL	$16.78 - $27.3 $247,890 - $403,302	-14,773 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$12.46 - $19.98 $184,071 - $295,164	14,773 New	14,773 $257,000

347

86.6M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.16B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.